An Overview of Young-Onset Parkinson's Disease - Clinical and Patient Perspectives
Registration |
---|
Two attendance options:
|
Target Audience
DMU faculty, staff, students, residents, and the medical community.
Educational Need
Parkinson's Disease (PD) is a progressive disorder that causes central nervous system degeneration and unintended neuromuscular symptoms such as tremors, stiffness, and difficulty with balance and coordination. It is considered young-onset PD (YOPD) when the individual is younger than 50. While the clinical presentation is similar to late-onset PD, YOPD patients experience symptoms and take medications for longer, contributing to a significantly greater risk of developing dyskinesias and dystonias. They also often face unique financial, family, and employment challenges that are less frequently an issue than their late-onset counterparts.
A positive aspect of YOPD is that younger brains are more neuroplastic, which allows the brain to respond to treatment more effectively. Participation in specialized movement programs early in the disease progression can maintain and even improve the loss of central nervous system function. Cases of YOPD should be referred to movement specialists as early as possible to ensure the best functional outcome for these individuals. Healthcare providers must be competent in identifying YOPD and can promptly initiate treatment for their younger-adult patients.
Objectives
- Recognize the typical clinical presentation and special considerations related to YOPD.
- Recall the most common pharmacological intervention for controlling YOPD and its side effects.
- Describe the indications for Deep Brain Stimulation in the management of YOPD.
- Explain the benefits and goals of exercise/movement-based interventions to improve symptoms and lessen the impact of the disease for individuals with YOPD.
- Reflect on how the patient perspective impacts healthcare providers.
Speakers
Allison Larson, PT, DPT, NCS | Danielle Horgen, MMS, PA-C |
Kelsee Hove, OTD, OTR/L, CBIS, DRS | Craig Haas |
Session proposals are now being accepted for the DMU Grand Rounds series! Have you encountered an interesting clinical case, seen a patient with a unique history, condition, and/or treatment protocol, or been involved with interprofessional management that improves patient care and treatment outcomes? If so, you're invited to help build the series by submitting a session proposal! In addition to the rare and unique, cases of more common conditions are also acceptable, and proposals from external members of the broader healthcare community are welcomed and encouraged. Please click the button below to learn more about the series and access the submission form.
Two attendance options:
- Des Moines University - No registration is necessary to attend on-site.
- Online - Register through Zoom.
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Craig Haas - Speaker
- Danielle Horgen, MMS, PA-C - Speaker
- Kelsee Hove, OTD, OTR/L, CBIS, DRS - Speaker
- Allison Larson, PT, DPT, NCS - Speaker
DISCLAIMER
The information provided at this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 1A
- 1.00 CE Contact Hour(s)
- 1.00 IBON
Price
Two attendance options:
- Des Moines University - No registration is necessary to attend on-site.
- Online - Register through Zoom.